NFKB1 and leukemia: Leukemic cells activate inflammatory pathways in BMSC, including AKT, ERK, PKCβII and NFκB pathways, which trigger an increased expression of inflammatory and wound healing associated proteins, ultimately resulting in an increased leukemia support5,6.